CVE-2022-26389

Name: CVE-2022-26389
Creator: NVD / NIST
Published: 2025-02-07T17:15:22.13+00:00
License: https://creativecommons.org/publicdomain/zero/1.0/

HIGHCVSS 7.7/10EPSS 0.27%

Last modified Jun 17, 2026

CVE-2022-26389 is a high-severity vulnerability rated 7.7/10 on the CVSS scale. An improper access control vulnerability may allow privilege escalation.This issue affects: * ELI 380 Resting Electrocardiograph: Versions 2.6.0 and prior; * ELI 280/BUR280/MLBUR 280 Resting Electrocardiograph: Versions 2.3.1 and prior; * ELI 250c/BUR 250c Resting Electrocardiograph: Versions 2.1.2 and prior; * ELI 150c/BUR 150c/MLBUR 150c Resting Electrocardiograph: Versions 2.2.0 and prior.. EPSS estimates a 0.27% chance of exploitation in the next 30 days.

Description

An improper access control vulnerability may allow privilege escalation.This issue affects: * ELI 380 Resting Electrocardiograph: Versions 2.6.0 and prior; * ELI 280/BUR280/MLBUR 280 Resting Electrocardiograph: Versions 2.3.1 and prior; * ELI 250c/BUR 250c Resting Electrocardiograph: Versions 2.1.2 and prior; * ELI 150c/BUR 150c/MLBUR 150c Resting Electrocardiograph: Versions 2.2.0 and prior.

Metrics

CVSS 3.1

7.7/10

CVSS:3.1/AV:N/AC:H/PR:L/UI:N/S:C/C:L/I:L/A:H

EPSS Probability

0.27%

19.1th percentile

Probability of exploitation in the next 30 days. Learn more

Weakness Enumeration

CWE-284

References

Timeline

Published: Feb 7, 2025
Last Modified: Jun 17, 2026
Status: Deferred

Frequently Asked Questions

What is CVE-2022-26389?

How severe is CVE-2022-26389?

CVE-2022-26389 has a CVSS score of 7.7/10 (HIGH severity). The EPSS model estimates a 0.27% probability of exploitation in the next 30 days.

How do I fix CVE-2022-26389?

Check the vendor references and advisories linked above for patched versions and mitigation guidance. You can also run a Strix scan to test if your systems are affected.

Are you affected by CVE-2022-26389?

Run a free Strix scan to check your systems for this vulnerability.

Scan your code now

Source: NVD / NIST